Biospectal mission to reinvent medical sensing and monitoring through ubiquitous connected devices, IoT, and edge computing technologies.
Biospectal has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in July 2021.
Biospectal's investors include MassChallenge, Privilège Ventures, LabCorp Venture Fund, SeedLink Ventures, Athensmed.
Biospectal is headquartered in Lausanne, Switzerland.
Biospectal mission to reinvent medical sensing and monitoring through ubiquitous connected devices, IoT, and edge computing technologies.
Biospectal is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biospectal — Funding & Investors." VCBacked, July 1, 2021, https://www.vcbacked.co/company/biospectal. Accessed July 20, 2026.
VCBacked. (2021). Biospectal — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/biospectal
{{cite web |title=Biospectal — Funding & Investors |url=https://www.vcbacked.co/company/biospectal |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated